|
Volumn 7, Issue 6, 2007, Pages 399-401
|
Targeting skeletal muscle AMP-activated protein kinase to treat type 2 diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
5 AMINO 4 IMIDAZOLECARBOXAMIDE;
ADIPONECTIN;
GLUCOSE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;
INSULIN;
LEPTIN;
METFORMIN;
PIOGLITAZONE;
RIBONUCLEOSIDE;
ROSIGLITAZONE;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
DISEASE MODEL;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG TARGETING;
DYSLIPIDEMIA;
ENZYME ACTIVATION;
ENZYME PHOSPHORYLATION;
ENZYME SUBUNIT;
EXERCISE;
HUMAN;
INCIDENCE;
INSULIN RESISTANCE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
NOTE;
SIGNAL TRANSDUCTION;
SKELETAL MUSCLE;
AMINOIMIDAZOLE CARBOXAMIDE;
ANIMALS;
DIABETES MELLITUS, TYPE 2;
ENZYME ACTIVATION;
ENZYME ACTIVATORS;
HUMANS;
HYPOGLYCEMIC AGENTS;
MICE;
MULTIENZYME COMPLEXES;
MUSCLE, SKELETAL;
PROTEIN SUBUNITS;
PROTEIN-SERINE-THREONINE KINASES;
RIBONUCLEOTIDES;
|
EID: 37349029044
PISSN: 15344827
EISSN: None
Source Type: Journal
DOI: 10.1007/s11892-007-0065-8 Document Type: Note |
Times cited : (1)
|
References (5)
|